BMS-986205
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for BMS-986205, covering 2018-02-28 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer [Phase 3]